Methotrexate eluting stents: to modify or cure?
作者信息
Morton A C, Gunn J
出版信息
Heart. 2004 Feb;90(2):121-2. doi: 10.1136/hrt.2003.019638.
Abstract
摘要
相似文献
1
Methotrexate eluting stents: to modify or cure?
Heart. 2004 Feb;90(2):121-2. doi: 10.1136/hrt.2003.019638.
2
Drug eluting stents in 2005.
Heart. 2005 Jun;91 Suppl 3(Suppl 3):iii24-31. doi: 10.1136/hrt.2005.060277.
3
UK introduces measures to reduce errors with methotrexate.
BMJ. 2003 Jul 12;327(7406):70. doi: 10.1136/bmj.327.7406.70.
4
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165.
5
[On special methods of use of folic acid antagonists in psoriasis].
G Ital Dermatol Minerva Dermatol. 1972 Apr;47(4):151-5.
6
Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Indian Heart J. 2008 May-Jun;60(3):228-32.
7
The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
Am J Cardiol. 2008 Jul 1;102(1):32-9. doi: 10.1016/j.amjcard.2008.03.051. Epub 2008 May 29.
8
Restenosis in a Bare-Metal Stent: Drug-Eluting Balloon or Drug-Eluting Stent?
Circ Cardiovasc Interv. 2016 Apr;9(4):e003829. doi: 10.1161/CIRCINTERVENTIONS.116.003829.
9
Polymer coating techniques for drug-eluting stents.
Med Device Technol. 2003;14(1):12-4.
10
Sirolimus-eluting stents: safe and effective in the treatment of in-stent restenosis.
Catheter Cardiovasc Interv. 2005 Oct;66(2):163-4. doi: 10.1002/ccd.20532.
本文引用的文献
1
Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
Heart. 2004 Feb;90(2):195-9. doi: 10.1136/hrt.2002.008169.
2
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.
3
Images in cardiovascular medicine. Late-late occlusion after intracoronary brachytherapy.
Circulation. 2003 Sep 9;108(10):e69-70. doi: 10.1161/01.CIR.0000083260.75983.C0.
4
Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.
Circulation. 2002 Oct 1;106(14):1867-73. doi: 10.1161/01.cir.0000033485.20594.6f.
5
Coronary artery stretch versus deep injury in the development of in-stent neointima.
Heart. 2002 Oct;88(4):401-5. doi: 10.1136/heart.88.4.401.
6
Intracoronary beta-radiation of de novo coronary lesions using a (186)Re liquid-filled balloon system: six-month results from a clinical feasibility study.
Catheter Cardiovasc Interv. 2002 Jan;55(1):28-36. doi: 10.1002/ccd.10043.
7
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
Circulation. 2001 Sep 4;104(10):1188-93. doi: 10.1161/hc3601.093987.
8
Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.
Circulation. 2001 Jul 24;104(4):473-9. doi: 10.1161/hc3001.092037.
9
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
Ann Rheum Dis. 2001 Aug;60(8):729-35. doi: 10.1136/ard.60.8.729.
10
Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
J Invasive Cardiol. 2001 Mar;13(3):193-201.
Zotero 插件